Lilly announces details of presentations at the 2024 American Society of Hematology (ASH) Annual Meeting
HO
Press Releases
November 5, 2024

Lilly announces details of presentations at the 2024 American Society of Hematology (ASH) Annual Meeting

INDIANAPOLIS, Nov. 5, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data from studies of Jaypirca® (pirtobrutinib), a non-covalent (reversible) Bruton's tyrosine kinase (BTK) inhibitor, will

bradford

The Bradford Era

More by this Author
Local & Social